Related Experiment Videos
Effect of pre-eclampsia on plasma cholinesterase activity
J R Kambam1, S Mouton, S Entman
1Vanderbilt University Medical Center, Department of Anesthesiology, Nashville, Tennessee.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie
|September 1, 1987
Summary
Plasma cholinesterase (PCHE) activity significantly decreases in pre-eclamptic pregnant women compared to healthy non-pregnant and pregnant individuals. This finding highlights PCHE as a potential biomarker for pre-eclampsia diagnosis.
Area of Science:
- Biochemistry
- Obstetrics
- Clinical Chemistry
Background:
- Plasma cholinesterase (PCHE) is an enzyme crucial for neurotransmission.
- Changes in PCHE activity can indicate various physiological and pathological conditions.
- Preeclampsia is a serious pregnancy complication characterized by hypertension and organ damage.
Purpose of the Study:
- To investigate and compare plasma cholinesterase (PCHE) activity levels in healthy non-pregnant women, healthy pregnant women, and pre-eclamptic pregnant women.
- To determine if PCHE activity is a reliable indicator of preeclampsia.
Main Methods:
- A colorimetric method was employed to measure PCHE activity.
- Blood samples were collected from three groups: 11 healthy non-pregnant women, 11 healthy pregnant women at term, and 11 pre-eclamptic pregnant women at term.
- Statistical analysis was performed to compare mean PCHE activities between groups.
Main Results:
- Mean PCHE activity in healthy non-pregnant women was 438 +/- 81 units/mL.
- Mean PCHE activity in healthy pregnant women was 257 +/- 25 units/mL.
- Mean PCHE activity in pre-eclamptic pregnant women was significantly reduced to 173 +/- 18 units/mL (p < 0.001).
Conclusions:
- Plasma cholinesterase activity is significantly lower in pre-eclamptic pregnant women compared to both healthy non-pregnant and healthy pregnant women.
- Reduced PCHE activity may serve as a potential biomarker for the early detection or assessment of preeclampsia.
- Further research is warranted to elucidate the exact mechanisms behind PCHE reduction in preeclampsia.